Shape Memory Medical

Shape Memory Medical is a San Jose, California medical-device company that develops endovascular embolization products built on its proprietary volume-expanding shape memory polymer (SMP) technology. Its IMPEDE and IMPEDE-FX embolization plugs are CE Marked and cleared in the US, with regulatory approvals in more than 40 countries and over 3,500 patients treated worldwide. The company is running the AAA-SHAPE randomized pivotal trial of its investigational IMPEDE-FX RapidFill device for abdominal aortic aneurysm sac management, alongside a FLAGSHIP first-in-human aortic dissection study.

  • Clinical Trials
  • Healthtech
  • Medical Devices
  • Healthcare & Life Sciences

1

Round

1

Industry

3

Tags

Aug 24, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Aug 24, 2026

    $10M

    Debt

    Led by August Global Partners

    • Taiwania Capital
    • Earlybird Venture Capital
    • HBM Healthcare Investments
    • August Global Partners
    • WexMed II, LLC

    Shape Memory Medical Secures $10M Debt Financing for Embolization Products

    Shape Memory Medical, a San Jose, California-based medical-device company, has raised $10 million in a debt financing round. The round was led by August Global Partners, with participation from Taiwania Capital, Earlybird Venture Capital, HBM Healthcare Investments, and WexMed II, LLC.

    Company Overview

    Shape Memory Medical develops endovascular embolization products based on its proprietary volume-expanding shape memory polymer (SMP) technology. Its IMPEDE and IMPEDE-FX embolization plugs are CE Marked and cleared in the US, with regulatory approvals in more than 40 countries. Over 3,500 patients have been treated worldwide with these devices.

    Clinical Trials

    The company is currently conducting the AAA-SHAPE randomized pivotal trial of its investigational IMPEDE-FX RapidFill device for abdominal aortic aneurysm sac management. Additionally, it is running a FLAGSHIP first-in-human aortic dissection study.

    Use of Funds

    The debt financing will likely support the company's ongoing clinical trials and regulatory efforts as it continues to expand its product portfolio and global reach.

Pricing

Research Shape Memory Medical — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Shape Memory Medical is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational